The Geneva-based medical device company Spineart already has a turnover of over €100 million and is continuing to expand. A new investment will enable the establishment of new production and training centres in Switzerland and the USA as well as the continued follow-up of patients enrolled in two clinical trials in which a new product for cervical disc replacement is being tested.
